Currently out of the existing stock ratings of Chad Mabry, 38 are a BUY (97.44%), 1 are a HOLD (2.56%).

Chad Mabry

Work Performance Price Targets & Ratings Chart

Analyst Chad Mabry, currently employed at B. RILEY, carries an average stock price target met ratio of 40% that have a potential upside of 19.48% achieved within 351 days. Previously, Chad Mabry worked at JONESTRADING, LADENBURG.

Chad Mabry’s has documented 79 price targets and ratings displayed on 13 stocks. The coverage is on Energy, Healthcare sectors.

Most recent stock forecast was given on MNOV, MediciNova at 16-Jun-2025.

Wall Street Analyst Chad Mabry

Analyst best performing recommendations are on ESTE (EARTHSTONE ENERGY).
The best stock recommendation documented was for ESTE (EARTHSTONE ENERGY) at 5/11/2016. The price target of $15 was fulfilled within 14 days with a profit of $3.43 (29.65%) receiving and performance score of 21.18.

Average potential price target upside

CPE Callon Petroleum Company CRZO Carrizo Oil & Gas ESTE Earthstone Energy GTBP GT Biopharma INMB INmune Bio ALT Altimmune MTDR Matador Resources Company QEP QEP Resources WPX WPX Energy MNOV MediciNova PDCE PDC Energy LGCY Legacy Education NVAX Novavax

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Feb-2024

$38

$2.24 (6.26%)

$40

2 years 6 months 18 days ago
(26-Feb-2024)

4/13 (30.77%)

$7.17 (23.26%)

14

Buy Since 13-Apr-2017

$32

$-3.76 (-10.51%)

$44

2 years 7 months 21 days ago
(23-Jan-2024)

1/10 (10%)

$0.42 (1.33%)

1

Buy Since 09-Mar-2022

$45

$9.24 (25.84%)

$51

2 years 8 months 5 days ago
(08-Jan-2024)

4/18 (22.22%)

$10.47 (30.32%)

9

Hold Since 19-Apr-2023

$40

$4.24 (11.86%)

$41

2 years 9 months 15 days ago
(29-Nov-2023)

1/4 (25%)

$8.43 (26.70%)

45

$40

$4.24 (11.86%)

$41

2 years 9 months 15 days ago
(29-Nov-2023)

3/14 (21.43%)

$8.43 (26.70%)

41

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Chad Mabry?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?